B+
Bull case
25%
Probability
Target price
$101.00
Analysis reference price unavailable
Analysis 2026-09-17 · RankAlpha Sentiment Codex
RDNT
RadNetBNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
55%
Probability
Target price
$88.00
Analysis reference price unavailable
Analysis 2026-09-17 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$56.00
Analysis reference price unavailable
Analysis 2026-09-17 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-09-17
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+73.0
Score
AI commentary
Primary-source news tone is constructive following record Q2 revenue and adjusted EBITDA, higher Imaging Center guidance, and strong advanced-imaging and Digital Health growth. The $75.78 anchor is above the pre-earnings price cited in stored coverage, indicating favorable price follow-through, but the packet does not provide a clean event-day return or evidence linking the full move to earnings. Social coverage is insufficient, while options skew, short interest, employee-review data and post-print analyst revisions are unavailable; zero-valued fields indicate missing evidence rather than neutral readings. Loose peers and incomplete valuation coverage constrain confidence.
RankAlpha Sentiment Codex - 2026-09-17
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-12-31eventRaised 2026 Imaging Center outlookMedium impact
After record second-quarter revenue of $622.7 million and adjusted EBITDA of $99.7 million, RadNet raised 2026 Imaging Center revenue, adjusted EBITDA and free-cash-flow guidance while reaffirming Digital Health guidance. Execution against the higher ranges is the principal year-end checkpoint. [#SEC-8K-2026-08-10]
2026-12-31catalystAdvanced-imaging volume and mix expansionHigh impact
Aggregate advanced-imaging volume increased 21.2%, same-center advanced-imaging volume rose 9.6%, and advanced imaging reached 29.9% of procedures versus 27.5% one year earlier. Sustained volume and mix gains could support center-level growth and margins. [#SEC-8K-2026-08-10]
2026-12-31catalystDigital Health recurring-revenue scalingHigh impact
Digital Health revenue increased 56.5% year over year and ARR reached $105.5 million, versus $53.5 million one year earlier. Further progress toward management's reported year-end ARR objective could improve the segment's strategic value, although infrastructure investment is suppressing near-term profitability. [#SEC-8K-2026-08-10]
Recommendation
N/A
No formal recommendation provided.
As of 2026-09-17 • Updated nightlySource: Internal modelMethodology